0 results available. Select is focused ,type to refine list, press Down to open the menu,
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating di...
The following section summarizes insights on Cytokinetics Inc's Unlevered Free Cash Flow:
We've identified the following companies as similar to Cytokinetics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Unlevered Free Cash Flow in the financials category include:
A cash flow measure that represents cash available to all providers of capital, including debt, equity, and hybrid capital. It is used to remove the i...
The Unlevered Free Cash Flow is calculated as follows:
EBIT
(x) (1 - Marginal Tax Rate)
(=) NOPAT
(+) Depreciation and Amortization
(-) Capital Expenditures
(-) Investment in Net Working Capital
(=) Unlevered Free Cash Flow
Read more about nopat, depreciation & amortization, capital expenditures, and net working capital
The chart above depicts the distribution of unlevered free cash flow for companies operating in the Healthcare sector in the Developed economic region. Over 2,535 companies were considered in this analysis, and 2,439 had meaningful values. The average unlevered free cash flow of companies in the sector is 24.46 M with a standard deviation of 203.2 M.
Cytokinetics Inc's Unlevered Free Cash Flow of -411.3 M is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,540 |
| Included Constituents | 2,439 |
| Min | -264.2 M |
| Max | 2.08 B |
| Median | -2.874 M |
| Mean | 24.46 M |
| Standard Deviation | 203.2 M |
You can find companies with similar unlevered free cash flow using this stock screener.